Pyridine features prominently in pharmaceuticals and drug leads,and methods to selectively manipulate pyridine basicity or metabolic stability are highly sought after.Arobust, metal-free direct fluorination of unactivated pyridylic CÀH bonds was developed. This convenient reaction shows high functional-group tolerance and offers complimentary selectivity to existing C À Hf luorination strategies.I mportantly,t his late-stage pyridylic C À Hfluorination provides opportunities to rationally modulate the basicity,l ipophilicity,a nd metabolic stability of alkylpyridine drugs.